Macrophages in melanoma: A double‑edged sword and targeted therapy strategies (Review)
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Macrophages in melanoma: A double‑edged sword and targeted therapy strategies (Review)
Authors
Keywords
-
Journal
Experimental and Therapeutic Medicine
Volume 24, Issue 4, Pages -
Publisher
Spandidos Publications
Online
2022-08-26
DOI
10.3892/etm.2022.11577
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cellular Carcinogenesis: Role of Polarized Macrophages in Cancer Initiation
- (2022) Ram Babu Undi et al. Cancers
- Intratumoral heterogeneity in cancer progression and response to immunotherapy
- (2021) Ilio Vitale et al. NATURE MEDICINE
- Inhibition of xCT suppresses the efficacy of anti-PD-1/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization
- (2021) Nian Liu et al. MOLECULAR THERAPY
- CAR-macrophage: A new immunotherapy candidate against solid tumors
- (2021) Yizhao Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non–Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1
- (2021) Sarah A. Weiss et al. CLINICAL CANCER RESEARCH
- Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics
- (2021) Farhad Islami et al. JNCI-Journal of the National Cancer Institute
- Blockade of TGF-βR improves the efficacy of doxorubicin by modulating the tumor cell motility and affecting the immune cells in a melanoma model
- (2021) Alireza Mardomi et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Overcoming PD-1 Blockade Resistance With CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients With Metastatic Melanoma
- (2021) Antoni Ribas et al. Cancer Discovery
- STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation
- (2021) Takashi Nakamura et al. Journal for ImmunoTherapy of Cancer
- Intra-Tumoral Activation of Endosomal TLR Pathways Reveals a Distinct Role for TLR3 Agonist Dependent Type-1 Interferons in Shaping the Tumor Immune Microenvironment
- (2021) Graham Thomas et al. Frontiers in Oncology
- MMP2 and TLRs modulate immune responses in the tumor microenvironment
- (2021) Luciana R. Muniz-Bongers et al. JCI Insight
- Myeloid-Derived Suppressive Cell Expansion Promotes Melanoma Growth and Autoimmunity by Inhibiting CD40/IL27 Regulation in Macrophages
- (2021) Julio C. Valencia et al. CANCER RESEARCH
- Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
- (2021) Golnaz Morad et al. CELL
- Endostatin inhibits the proliferation and migration of B16 cells by inducing macrophage polarity to M1‑type
- (2021) Hua Guo et al. Molecular Medicine Reports
- Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
- (2021) Christopher Sloas et al. Frontiers in Immunology
- Macrophage Reprogramming and Cancer Therapeutics: Role of iNOS-Derived NO
- (2021) Khosrow Kashfi et al. Cells
- CAR T cells: continuation in a revolution of immunotherapy
- (2020) Anurag K Singh et al. LANCET ONCOLOGY
- Melanoma-Derived Exosomal miR-125b-5p Educates Tumor Associated Macrophages (TAMs) by Targeting Lysosomal Acid Lipase A (LIPA)
- (2020) Dennis Gerloff et al. Cancers
- Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice
- (2020) Sharmilla Devi Jayasingam et al. Frontiers in Oncology
- Annual report to the nation on the status of cancer, part I: National cancer statistics
- (2020) S. Jane Henley et al. CANCER
- Human chimeric antigen receptor macrophages for cancer immunotherapy
- (2020) Michael Klichinsky et al. NATURE BIOTECHNOLOGY
- Irradiated tumor cell–derived microparticles mediate tumor eradication via cell killing and immune reprogramming
- (2020) Chao Wan et al. Science Advances
- Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages
- (2020) Marta Di Martile et al. Journal for ImmunoTherapy of Cancer
- Macrophage M1/M2 polarization
- (2020) Chen Yunna et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- M2 macrophage‐derived exosomes facilitate hepatocarcinoma metastasis by transferring α M β 2 integrin to tumor cells
- (2020) Jindao Wu et al. HEPATOLOGY
- Adoptive T Cell Therapy Targeting Different Gene Products Reveals Diverse and Context-Dependent Immune Evasion in Melanoma
- (2020) Maike Effern et al. IMMUNITY
- M2-Like Tumor-Associated Macrophage-Targeted Codelivery of STAT6 Inhibitor and IKKβ siRNA Induces M2-to-M1 Repolarization for Cancer Immunotherapy with Low Immune Side Effects
- (2020) Hong Xiao et al. ACS Central Science
- Targeting tumor-associated macrophages for cancer immunotherapy
- (2020) Yongheng Shu et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Macrophages Mediate the Anti-Tumor Effects of the Oncolytic Virus HSV1716 in Mammary Tumors
- (2020) Amy Kwan et al. MOLECULAR CANCER THERAPEUTICS
- Targeting Tumor-Associated Macrophages in Cancer
- (2019) Paulina Pathria et al. TRENDS IN IMMUNOLOGY
- Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix
- (2019) Wenlong Zhang et al. BRITISH JOURNAL OF CANCER
- From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
- (2019) Yaojie Fu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment
- (2019) Monica Marzagalli et al. SEMINARS IN CANCER BIOLOGY
- Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor
- (2019) Sourav Paul et al. Journal for ImmunoTherapy of Cancer
- TRIM59 loss in M2 macrophages promotes melanoma migration and invasion by upregulating MMP-9 and Madcam1
- (2019) Yuan Tian et al. Aging-US
- Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses
- (2019) Anfray et al. Cells
- Inhibition of Rspo-Lgr4 facilitates checkpoint blockade therapy by switching macrophage polarization
- (2018) Binghe Tan et al. CANCER RESEARCH
- M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma
- (2018) Magdalena Jarosz-Biej et al. PLoS One
- NFAT1 enhances the effects of tumor-associated macrophages on promoting malignant melanoma growth and metastasis
- (2018) Hao Liu et al. BIOSCIENCE REPORTS
- Targeting macrophages: therapeutic approaches in cancer
- (2018) Luca Cassetta et al. NATURE REVIEWS DRUG DISCOVERY
- Connexin 43 upregulation by dioscin inhibits melanoma progression via suppressing malignancy and inducing M1 polarization
- (2017) Yu Kou et al. INTERNATIONAL JOURNAL OF CANCER
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Targeting macrophage anti-tumor activity to suppress melanoma progression
- (2017) Huafeng Wang et al. Oncotarget
- Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature
- (2017) Xixi Zhao et al. Oncotarget
- Pro-tumor activities of macrophages in the progression of melanoma
- (2017) Huafeng Wang et al. Human Vaccines & Immunotherapeutics
- The Prognostic and Clinicopathological Significance of Tumor-Associated Macrophages in Patients with Gastric Cancer: A Meta-Analysis
- (2017) Songcheng Yin et al. PLoS One
- Relative Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor, Dacarbazine, and Glycoprotein 100 in Metastatic Melanoma: An Indirect Treatment Comparison
- (2016) Casey Quinn et al. ADVANCES IN THERAPY
- Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma
- (2016) Baoping Guo et al. BMC Medicine
- Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma
- (2016) Christoph Hoeller et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MFG-E8 Drives Melanoma Growth by Stimulating Mesenchymal Stromal Cell–Induced Angiogenesis and M2 Polarization of Tumor-Associated Macrophages
- (2016) Kazuya Yamada et al. CANCER RESEARCH
- Antagonizing Integrin 3 Increases Immunosuppression in Cancer
- (2016) X. Su et al. CANCER RESEARCH
- NFAT1 Directly Regulates IL8 and MMP3 to Promote Melanoma Tumor Growth and Metastasis
- (2016) E. Shoshan et al. CANCER RESEARCH
- Tissue-Resident Macrophage Ontogeny and Homeostasis
- (2016) Florent Ginhoux et al. IMMUNITY
- Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
- (2016) Antoni Ribas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Melanoma exosome induction of endothelial cell GM-CSF in pre-metastatic lymph nodes may result in different M1 and M2 macrophage mediated angiogenic processes
- (2016) Joshua L. Hood MEDICAL HYPOTHESES
- The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
- (2016) Danny N. Khalil et al. Nature Reviews Clinical Oncology
- Specification of tissue-resident macrophages during organogenesis
- (2016) E. Mass et al. SCIENCE
- Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment
- (2016) Wei Bin Fang et al. Oncotarget
- Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis
- (2016) Jiandong Mei et al. Oncotarget
- Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
- (2016) Anna-Maria Georgoudaki et al. Cell Reports
- Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies
- (2016) Robert L. Bowman et al. Cell Reports
- Macrophages and Therapeutic Resistance in Cancer
- (2015) Brian Ruffell et al. CANCER CELL
- Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab
- (2015) Zeynep Eroglu et al. EUROPEAN JOURNAL OF CANCER
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
- (2015) Dirk Schadendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma
- (2014) F. Stephen Hodi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effective Innate and Adaptive Antimelanoma Immunity through Localized TLR7/8 Activation
- (2014) Manisha Singh et al. JOURNAL OF IMMUNOLOGY
- CSF-1 Receptor Signaling in Myeloid Cells
- (2014) E. R. Stanley et al. Cold Spring Harbor Perspectives in Biology
- The Immune Microenvironment Confers Resistance to MAPK Pathway Inhibitors through Macrophage-Derived TNF
- (2014) M. P. Smith et al. Cancer Discovery
- Clinical significance of macrophage heterogeneity in human malignant tumors
- (2013) Yoshihiro Komohara et al. CANCER SCIENCE
- Targeting BRAF in melanoma: Biological and clinical challenges
- (2013) Mario Mandalà et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma
- (2012) P. A. Prieto et al. CLINICAL CANCER RESEARCH
- Regulation of EMT by TGFβ in cancer
- (2012) Carl-Henrik Heldin et al. FEBS LETTERS
- Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
- (2012) Qiong-wen Zhang et al. PLoS One
- Epigenetic regulation of macrophage polarization and function
- (2012) Lionel B. Ivashkiv TRENDS IN IMMUNOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
- (2010) K. Movahedi et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search